Ginkgo Bioworks Holdings, Inc. (DNABW)

OTCMKTS · Delayed Price · Currency is USD · Warrants
0.0120
+0.0040 (50.00%)
Jul 18, 2025, 4:00 PM EDT
2,300%
Market Cap680.51M
Revenue (ttm)217.95M
Net Income (ttm)-651.19M
Shares Outn/a
EPS (ttm)-12.86
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume103,000
Average Volume53,287
Open0.0104
Previous Close0.0080
Day's Range0.0104 - 0.0120
52-Week Range0.0005 - 0.0249
Betan/a
RSI56.17
Earnings DateFeb 28, 2025

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2008
Employees 834
Stock Exchange OTCMKTS
Ticker Symbol DNABW
Full Company Profile

News

There is no news available yet.